40
Participants
Start Date
August 1, 2017
Primary Completion Date
October 15, 2019
Study Completion Date
May 31, 2020
Barostim neo implantation
"The Barostim neo Implantation is a new promising treatment option for patients with advanced heart failure (HEFrEF) as it might improve cardiac and vascular function by restoring sympathovagal-balance through its effects on the autonomic nervous system.~In this observational study, data from patients who have received the Barostim neo System as part of clinical routine will be collected and analyzed. The implantation of this new device is not part of the study."
Herz- und Diabeteszentrum NRW, Bad Oeynhausen
Heart and Diabetes Center North-Rhine Westfalia
OTHER